BOZZATO, DANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.431
AS - Asia 2.830
EU - Europa 1.768
SA - Sud America 600
AF - Africa 554
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 41
AN - Antartide 1
Totale 12.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.057
SG - Singapore 1.046
CN - Cina 663
BR - Brasile 431
HK - Hong Kong 335
PL - Polonia 220
FI - Finlandia 199
IT - Italia 187
SE - Svezia 177
VN - Vietnam 169
DE - Germania 137
RU - Federazione Russa 89
NL - Olanda 84
GB - Regno Unito 82
FR - Francia 77
UA - Ucraina 58
CA - Canada 51
IN - India 46
MX - Messico 42
ID - Indonesia 34
ES - Italia 33
IQ - Iraq 33
JP - Giappone 32
KR - Corea 32
ZA - Sudafrica 30
BW - Botswana 28
SA - Arabia Saudita 28
AR - Argentina 26
EG - Egitto 26
TR - Turchia 26
AT - Austria 25
IE - Irlanda 23
UG - Uganda 23
GT - Guatemala 22
PA - Panama 22
PT - Portogallo 22
RO - Romania 22
NP - Nepal 21
PR - Porto Rico 21
TJ - Tagikistan 21
AO - Angola 20
CO - Colombia 20
HR - Croazia 20
LC - Santa Lucia 20
MD - Moldavia 20
AZ - Azerbaigian 19
DK - Danimarca 19
EC - Ecuador 19
GF - Guiana Francese 19
TN - Tunisia 19
BZ - Belize 18
CW - ???statistics.table.value.countryCode.CW??? 18
CY - Cipro 18
EE - Estonia 18
KZ - Kazakistan 18
LY - Libia 18
PY - Paraguay 18
TZ - Tanzania 18
BA - Bosnia-Erzegovina 17
BG - Bulgaria 17
BY - Bielorussia 17
CI - Costa d'Avorio 17
CL - Cile 17
CR - Costa Rica 17
CV - Capo Verde 17
DO - Repubblica Dominicana 17
GR - Grecia 17
SO - Somalia 17
TW - Taiwan 17
AU - Australia 16
BB - Barbados 16
BD - Bangladesh 16
EU - Europa 16
GN - Guinea 16
LB - Libano 16
PE - Perù 16
PK - Pakistan 16
SK - Slovacchia (Repubblica Slovacca) 16
UZ - Uzbekistan 16
AL - Albania 15
CM - Camerun 15
CU - Cuba 15
CZ - Repubblica Ceca 15
GP - Guadalupe 15
JO - Giordania 15
ME - Montenegro 15
TT - Trinidad e Tobago 15
ZM - Zambia 15
DZ - Algeria 14
IL - Israele 14
IR - Iran 14
JM - Giamaica 14
KH - Cambogia 14
MY - Malesia 14
MZ - Mozambico 14
NE - Niger 14
RW - Ruanda 14
AD - Andorra 13
BO - Bolivia 13
DM - Dominica 13
Totale 11.686
Salva come PNG Salva come JPEG
Città #
Singapore 635
Woodbridge 621
Ashburn 573
Chandler 553
Ann Arbor 550
Fairfield 543
Houston 506
Hong Kong 310
Cambridge 217
Wilmington 214
Seattle 193
Bytom 185
Beijing 161
Jacksonville 160
Boardman 155
Santa Clara 129
Des Moines 117
Princeton 114
Medford 103
Helsinki 83
Dong Ket 79
Los Angeles 78
Nanjing 75
Roxbury 57
San Diego 54
Padova 53
São Paulo 50
New York 37
Buffalo 35
Redondo Beach 34
Ho Chi Minh City 33
Jinan 30
Munich 30
Shenyang 27
Hanoi 23
Hebei 23
Kampala 23
Nanchang 22
Warsaw 22
Chicago 21
Gaborone 20
Panama City 20
Castries 19
Dushanbe 19
Guangzhou 19
Luanda 19
Tianjin 18
Baku 17
Cairo 17
Changsha 17
London 17
Zhengzhou 17
Dallas 16
Dublin 16
Guatemala City 16
Jiaxing 16
Abidjan 15
Amsterdam 15
Cayenne 15
Conakry 15
Dar es Salaam 15
Johannesburg 15
Lusaka 15
Milan 15
Montreal 15
Praia 15
Tokyo 15
Toronto 15
Bridgetown 14
Chisinau 14
Hefei 14
Kigali 14
Phnom Penh 14
Tallinn 14
Tashkent 14
Turku 14
Willemstad 14
Amman 13
Andorra la Vella 13
Baghdad 13
Havana 13
Managua 13
Noumea 13
San José 13
Tripoli 13
Vienna 13
Bamako 12
Dakar 12
Jeddah 12
Lima 12
Niamey 12
Nowon-gu 12
Riyadh 12
Roseau 12
San Francisco 12
Stockholm 12
Accra 11
Bishkek 11
Harare 11
Limassol 11
Totale 7.798
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 244
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 223
Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis 220
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 219
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 211
Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability 204
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis 202
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 178
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 176
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 174
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 169
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 167
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 167
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 166
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 163
SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells 162
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 159
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 156
MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers 155
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 149
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 147
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 146
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 142
SARS-CoV-2 RNA identification in nasopharyngeal swabs: Issues in pre-analytics 142
Convergence and cooperativity between EGFR, TGFB, insulin and S100A8/A9 signaling in PDAC 133
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 133
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 127
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 127
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 126
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 124
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 124
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 124
Convergence and cooperativity between EGFR, TGFb, insulin and S100A8/A9 signaling in pancreatic ductal adenocarcinoma (PDAC) 123
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 119
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 119
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 119
Analogs of vitamin e epitomized by α-tocopheryl succinate for pancreatic cancer treatment: In vitro results induce caution for in vivo applications 119
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 117
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 115
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 115
NT-S100A8 effects on cell signalling. 114
Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico 114
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 114
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 112
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 111
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 111
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 109
SMAD-4 related and unrelated soluble factors and exosomes co-operate in determining pancreatic adenocarcinoma (PDAC) immunoevasion 109
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 108
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 107
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 107
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 107
PANCREATIC CANCER (PaCa)-DERIVED SOLUBLE MEDIATORS INDUCE DENDRITIC CELLS (DC) TO ACQUIRE AN IMMUNESUPPRESSIVE PHENOTYPE BY DOWNREGULATING CTLA4 106
The Inflammatory Molecules S100A8 and TGF-b1 Activate the Epithelial-Mesenchymal Transition Process in Pancreatic Cancer Cells 106
Tumor necrosis factor alpha (TNFa) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk. 105
Epidermal growth factor (EGF) chronic stimulation causes Smad4- dependent signaling bypass in pancreatic ductal adenocarcinoma (PDAC) 104
Genome-wide association study identifies an early onset pancreatic cancer risk locus 104
Hyperglycemia-Induced S100A8 and S100A9 Target Akt and NF-kB Signalling in Pancreatic Cancer Cells. 103
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 103
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 102
THE CagL Glu59 POLYMORPHISM OF H. pylori IS ASSOCIATED WITH AN INCREASED RISK OF GASTRIC CANCER. PRELIMINARY RESULTS FROM AN ITALIAN MULTICENTER STUDY 100
Epidermal growth factor (EGF) chronic stimulation causes Smad4-dependent signaling bypass in PDAC 99
Pancreatic cancer induced diabetes mellitus: relevance of the S100A8 N-terminal peptide (Nt-S100A8). 99
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 98
Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells 97
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 97
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 96
MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) Are Correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus 94
Discovery of new serum biomarkers for pancreatic cancer diagnosis by Maldi-Tof analysis. 93
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 93
Polimorfismi dei geni KLK3, RASA1 e NAALADL2: rischio di cancro alla prostata, aggressività della neoplasia e livelli sierici dell’Antigene Prostatico-Specifico 93
Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results. 92
The CagL GLU59 Polymorphism of H. pylori is associated with an increasedrisk of gastric cancer. Preliminaryresults from an Italian multicenter study. 91
Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle. 90
KLK3 and Steroid 5-alpha Reductase TypeII (SRD5A2) gene polymorphisms affect clinical reliability of serum PSA measurement. 89
Blood expression of matrix metallo-proteinases 8 and 9 and of their inducers S100A8 and S100A9 support diagnosis and prognosis of PDAC-associated diabetes mellitus. 88
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 87
Hyperglycemia-induced S100A8 and S100A9 target Akt and NF-kB signaling in pancreatic cancer cells. 86
SMAD4 RELATED TRANSFER THROUGH EXOSOMES OF GLYCOLYTIC ENZYMES AND miR-1260 UNDERLIES THE REVERSE WARBURG EFFECT IN PDAC 86
S100A8 and S100A9 target AKT, mTOR and NF-KB signalling in pancreatic cancer cells. 85
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 85
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 84
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 84
Aeskulisa and H-TTG/DGP scren for celiac disease diagnosis 84
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 82
Erythrocyte sedimentation rate and c-reactive protein in acute inflammation: Meta-analysis of diagnostic accuracy studies 82
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival 82
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 81
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk 81
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 80
Hypergycemia-induced S100A8 and S100A9 expression target AKT, and NF-KB signalling in pancreatic cancer cells. 80
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 79
Quality indicators to monitor the rejected outpatients' samples 79
SMAD4 LOSS ENABLES EGF, TGFB1 AND S100A8/ A9 INDUCED ACTIVATION OF CRITICAL PATHWAYS TO PANCREATIC CANCER INVASION 77
The Inflammatory Calcium Binding Protein S100A8 and Its N-Terminal Proteolytic Fragment Interact with Transforming Growth Factor-Beta1 (TGF-b1) and Alter Akt, mTOR and NF-kappa B Cancer Cell Signalling. 76
Discovery of new serum biomarkers for pancreatic cancer diagnosis by MALDI-TOF analysis. 75
Pancreatic Cancer Alters CD4+T Lymphocyte Function: A Piece of the Immunevasion Puzzle 75
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 75
Clinical Relevance of Circulating and Splenic Immature Myeloid Cells in Pancreatic Diseases. 73
The inflammatory molecules S100A8 and TGF-b1 activate the epithelial-mesenchymal transition (EMT) process in pancreatic cancer (PaCa) cells 73
Totale 11.801
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.931
article - articoli 16.920
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021678 0 0 0 0 45 45 34 47 99 133 104 171
2021/2022952 14 182 48 49 43 98 31 75 49 13 65 285
2022/20231.164 206 127 13 131 197 169 4 76 158 9 44 30
2023/2024592 23 70 70 49 46 63 53 65 18 36 40 59
2024/20252.522 14 128 133 121 320 54 118 199 220 96 486 633
2025/20263.388 428 766 1.135 993 66 0 0 0 0 0 0 0
Totale 12.353